Trading in Science: A Volatile Mix of Stock Prices and Embargoed Data

See allHide authors and affiliations

Science  30 Oct 1998:
Vol. 282, Issue 5390, pp. 865
DOI: 10.1126/science.282.5390.865

You are currently viewing the summary.

View Full Text


The relationship between science publicity and big money is becoming increasingly complex, particularly in the biotechnology area. News of developments is eagerly sought by investors, and companies love the publicity that publication in a major journal brings. But problems can crop up while a paper is going through review and is under prepublication embargo, most notably with regard to the potential for insider trading.